Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Salarius Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:SLRX | Benzinga

Q: What sector and industry does Salarius Pharmaceuticals (SLRX) operate in?

Salarius Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Salarius Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SLRX.

Open	$1.25
Close	-
Volume / Avg.	51.04M / 376.16K
Day Range	$0.84 - $1.26
52 Wk Range	0.45 - 7.20
Market Cap	$2.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	71
Short Interest	2.27%
Days to Cover	2.61

Recent News

Why Lennar Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt

Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company.

Anthony Noto

Salarius Pharmaceuticals Shares Are Skyrocketing Today: What's Going On?

Salarius Pharmaceuticals (NASDAQ: SLRX) shares are trading higher Monday after the company announced a merger agreement with Decoy Therapeutics, a privately held biopharmaceutical company.

Vaishali Prayag

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$1.25
Close	-
Volume / Avg.	51.04M / 376.16K
Day Range	$0.84 - $1.26
52 Wk Range	0.45 - 7.20
Market Cap	$2.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	71
Short Interest	2.27%
Days to Cover	2.61

About Salarius Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing eff...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Salarius Pharmaceuticals (SLRX) stock?

You can purchase shares of Salarius Pharmaceuticals (NASDAQ:SLRX) through any online brokerage.

View our list of the best stock brokerages

Who are Salarius Pharmaceuticals (SLRX) competitors?

Other companies in Salarius Pharmaceuticals’s space includes: Plus Therapeutics (NASDAQ:PSTV), Alzamend Neuro (NASDAQ:ALZN), Bone Biologics (NASDAQ:BBLG), Entero Therapeutics (NASDAQ:ENTO) and Qualigen Therapeutics (NASDAQ:QLGN).

What is the forecast, or price target, for Salarius Pharmaceuticals (SLRX) stock?

There is no analysis for Salarius Pharmaceuticals to provide a consensus price target.

What is the current price for Salarius Pharmaceuticals (SLRX)?

The stock price for Salarius Pharmaceuticals (NASDAQ: SLRX) is $0.97 last updated June 17, 2025 at 2:49 PM EDT.

Does Salarius Pharmaceuticals (SLRX) pay a dividend?

There are no upcoming dividends for Salarius Pharmaceuticals.

When is Salarius Pharmaceuticals (NASDAQ:SLRX) reporting earnings?

Salarius Pharmaceuticals’s Q2 earnings are confirmed for Friday, August 8, 2025.

Is Salarius Pharmaceuticals (SLRX) going to split?

There is no upcoming split for Salarius Pharmaceuticals.

What sector and industry does Salarius Pharmaceuticals (SLRX) operate in?

Salarius Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Salarius Pharmaceuticals Stock Price, Quotes and Forecasts

Salarius Pharmaceuticals (SLRX) Forecast